FancyFinancy @FancyFinancy

Info--not advice. Small-Cap, VC, Alt Lending. Impact Investing. Crowd Funding. A media account powered by Content Carnivores. contentcarnivores.com/disclaimer/ Chicago Joined October 2013

Tweets

61K
Followers

6K
Following

6K
Likes

1K

FancyFinancy @FancyFinancy

4 months ago

GeoVax Responds to Detection of Clade I #Mpox in North Carolina Wastewater $GOVX geovax.com/investors/pres…

1 0 0 113 0

FancyFinancy @FancyFinancy

4 months ago

geovax.com/investors/pres…

0 0 0 21 0

FancyFinancy @FancyFinancy

4 months ago

GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations geovax.com/investors/pres… $GOVX

0 0 0 43 0

HHS Secretary Robert F. Kennedy Jr. told CBS News that single-strain vaccines aren't effective for fast-mutating respiratory viruses. The FDA is now focusing on multi-strain vaccines, benefiting GeoVax's polyvalent COVID-19 vaccine GEO-CM04S1. $GOVX buff.ly/Li6aH8h

0 1 0 101 0

FancyFinancy @FancyFinancy

5 months ago

Utah is swiftly emerging as a hotspot for life sciences, bolstered by the robust expansion of commercial real estate propelling this vibrant industry. Uncover the reasons behind Utah's allure for innovation and investment! #UtahInnovation #LifeSciences colliers.com/en/news/salt-l…

0 0 0 17 0

Download Image

FancyFinancy @FancyFinancy

9 months ago

$GOVX to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on buff.ly/2OS5KKp #mpox #immunocompromised #mva

0 0 0 105 0

FancyFinancy @FancyFinancy

9 months ago

$GOVX working on addressing the shortage of available #MPOX vaccine. Update from CEO on the disease and the growing need here. buff.ly/3CIJSyW

0 1 0 138 0

FancyFinancy @FancyFinancy

10 months ago

$GOVX milestones met, including plans for a Phase 2 trial of Gedeptin for first recurrent head and neck cancer in combination with an immune checkpoint inhibitor. Full report here. buff.ly/3AJwQkj

0 0 0 76 0

FancyFinancy @FancyFinancy

10 months ago

Joshua Hill, MD, who headed the ImmunOptimize scientific committee. “We need a grassroots effort to address the unmet needs of immunocompromised patients. The time is right to bring the conversations to the forefront.” #COVID $GOVX buff.ly/3BYHALO

0 0 0 75 0

B2i Digital @b2idigital

11 months ago

We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @b2idigital at b2idigital.com/3rd-annual-rot… GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and…

3 19 11 3K 0

Download Image

FancyFinancy @FancyFinancy

a year ago

#WHO Q&A on #mpox refreshed with latest information buff.ly/3HO1wzN

0 0 0 55 0

FancyFinancy @FancyFinancy

a year ago

buff.ly/46QWmzK

0 0 0 22 0

FancyFinancy @FancyFinancy

a year ago

Follow-Through Friday buff.ly/4a5Ma6f

0 0 0 22 0

Download Image

FancyFinancy @FancyFinancy

2 years ago

#vaccines #COVID19 #immunocompromised #MVA $GOVX Both antibody-and cell-mediated responses should be considered in assessing vaccine immunogenicity. The study also highlights the importance of vaccination in immunocompromised patients. buff.ly/48yOfrb